Travelers shares slide as post-earnings valuation concerns weigh on the stock

The Travelers Companies (TRV) is down 3.9% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is a valuation pullback after Travelers’ sharp rally following its strong second-quarter results. Even though the company posted excellent earnings, several analysts turned more cautious this month, suggesting the stock’s run-up may have outpaced near-term upside.

Details:

Travelers reported strong second-quarter 2026 results on July 17, including net income of $2.208 billion, core income of $2.160 billion, and core EPS of $10.04, helped by lower catastrophe losses, favorable reserve development, and higher investment income.

The company’s combined ratio improved to 83.6%, catastrophe losses fell to $518 million from $927 million a year earlier, and after-tax net investment income rose 14% to $883 million, showing very strong operating performance.

After that earnings-driven surge, the stock reached record territory and drew a wave of analyst downgrades in July centered on valuation rather than deteriorating fundamentals.

This could be because investors are taking profits after a strong run, especially as the market reassesses how much more upside remains after such a large earnings beat.

Sources:

SEC, Travelers Investor Relations, Bloomberg Law

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$TRV Insider Trading Activity

$TRV insiders have traded $TRV stock on the open market 46 times in the past 6 months. Of those trades, 0 have been purchases and 46 have been sales.

Here’s a breakdown of recent trading of $TRV stock by insiders over the last 6 months:

ALAN D SCHNITZER (Chairman and CEO) has made 0 purchases and 3 sales selling 55,733 shares for an estimated $16,424,516.
MICHAEL FREDERICK KLEIN (EVP & President, Personal Ins.) has made 0 purchases and 8 sales selling 36,000 shares for an estimated $11,322,581.
MOJGAN M LEFEBVRE (EVP & Chief Tech & Ops Officer) has made 0 purchases and 3 sales selling 22,139 shares for an estimated $7,747,142.
DANIEL S. FREY (EVP & Chief Financial Officer) has made 0 purchases and 3 sales selling 22,037 shares for an estimated $7,564,962.
MARIA OLIVO (EVP, ERM & Chief Risk Officer) has made 0 purchases and 2 sales selling 20,800 shares for an estimated $6,316,420.
ANDY F BESSETTE (EVP and Chief Admin Officer) has made 0 purchases and 6 sales selling 13,255 shares for an estimated $4,201,270.
WILLIAM H HEYMAN (Vice Chairman) has made 0 purchases and 9 sales selling 13,557 shares for an estimated $4,130,425.
GREGORY C TOCZYDLOWSKI (EVP & President, Business Ins.) sold 12,199 shares for an estimated $3,656,983
AVROHOM J. KESS (Vice Chmn. & Chief Legal Off.) has made 0 purchases and 2 sales selling 11,491 shares for an estimated $3,508,540.
DANIEL TEI-HWA YIN (EVP & Co-Chief Invest. Officer) sold 7,153 shares for an estimated $2,768,211
DIANE KURTZMAN (EVP & Chief HR Officer) has made 0 purchases and 3 sales selling 7,031 shares for an estimated $2,480,240.
JEFFREY P. KLENK (EVP & Pres., Bond & Spec. Ins.) sold 6,413 shares for an estimated $1,956,549
DAVID DONNAY ROWLAND (EVP & Co-Chief Invest. Officer) sold 5,000 shares for an estimated $1,858,440
PAUL E. MUNSON (SVP & Corp. Controller) has made 0 purchases and 3 sales selling 5,252 shares for an estimated $1,704,716.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$TRV Hedge Fund Activity

We have seen 766 institutional investors add shares of $TRV stock to their portfolio, and 727 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CURATED WEALTH PARTNERS LLC added 2,756,660 shares (+346314.1%) to their portfolio in Q2 2026, for an estimated $910,028,599
FMR LLC removed 835,366 shares (-6.5%) from their portfolio in Q1 2026, for an estimated $243,659,554
AQR CAPITAL MANAGEMENT LLC added 748,066 shares (+43.7%) to their portfolio in Q1 2026, for an estimated $218,195,890
BLACKROCK, INC. removed 671,358 shares (-3.0%) from their portfolio in Q1 2026, for an estimated $195,821,701
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM removed 417,686 shares (-39.6%) from their portfolio in Q1 2026, for an estimated $121,830,652
AMUNDI added 373,061 shares (+36.6%) to their portfolio in Q1 2026, for an estimated $108,814,432
VOYA INVESTMENT MANAGEMENT LLC added 371,600 shares (+1055.6%) to their portfolio in Q1 2026, for an estimated $108,388,288

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$TRV Congressional Stock Trading

Members of Congress have traded $TRV stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $TRV stock by members of Congress over the last 6 months:

SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.
REPRESENTATIVE JULIA LETLOW purchased up to $15,000 on 02/20.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$TRV Analyst Ratings

Wall Street analysts have issued reports on $TRV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Cantor Fitzgerald issued a "Overweight" rating on 02/02/2026

To track analyst ratings and price targets for $TRV, check out Quiver Quantitative's $TRV forecast page.

$TRV Price Targets

Multiple analysts have issued price targets for $TRV recently. We have seen 14 analysts offer price targets for $TRV in the last 6 months, with a median target of $333.5.

Here are some recent targets:

Yaron Kinar from Mizuho set a target price of $324.0 on 07/09/2026
Elyse Greenspan from Wells Fargo set a target price of $334.0 on 07/09/2026
Ryan Tunis from Cantor Fitzgerald set a target price of $360.0 on 07/09/2026
Meyer Shields from Keefe, Bruyette & Woods set a target price of $356.0 on 07/08/2026
Brian Meredith from UBS set a target price of $350.0 on 07/08/2026
Bob Huang from Morgan Stanley set a target price of $333.0 on 07/08/2026
Vikram Gandhi from HSBC set a target price of $351.0 on 07/06/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.